Equity Capital Markets

Company · CIK 2012593

Rapport Therapeutics, Inc.

CIK2012593 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressMA
ListedRAPP (Nasdaq)
First annual or quarterly report2024-08-08

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-294170
ShelfEffective
2026-03-102026-03-101
333-288444
ShelfEffective
2025-07-012026-01-075
333-288445
ShelfEffective
2025-07-012025-07-092
333-279486
IPOFinal prospectus
2024-05-172024-06-074

Filings

13
FiledFilingRegistrationAccession
2026-03-10S-3ASRShelf registered 333-2941700001193125-26-099421
2026-01-07424B5Shelf takedown 333-2884440001193125-26-005482
2025-09-10424B5Shelf takedown 333-2884440001193125-25-200200
2025-09-08424B5Shelf takedown 333-2884440001193125-25-198453
2025-07-09EFFECTDeclared effective 333-2884459999999995-25-002211
2025-07-09EFFECTDeclared effective 333-2884449999999995-25-002210
2025-07-01S-3Shelf registered 333-2884450001193125-25-153417
2025-07-01S-3Shelf registered 333-2884440001193125-25-153415
2024-06-07424B4Final prospectus 333-2794860001193125-24-157358
2024-06-06EFFECTDeclared effective 333-2794869999999995-24-001768
2024-06-03S-1/AAmendment 333-2794860001193125-24-152294
2024-05-17S-1Registration filed 333-2794860001193125-24-141704
2024-03-27DRSDraft made public 377-071530000950123-24-003008

All filings of this company · CSV